Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human iNOS ELISA Kit (AC2425)
Cat.#: ASET-1014
Specifications
Description Human iNOS ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human iNOS concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.11 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2524 Rat VEGFB ELISA Kit (AC3935) Quantitative inquiry ASET-1008 Human KCNJ4 ELISA Kit (AC2419) Quantitative inquiry ASET-1258 Human PCDH1 ELISA Kit (AC2669) Quantitative inquiry ASET-1551 Human alpha 2a Adrenergic Receptor ELISA Kit (AC2962) Quantitative inquiry ASET-2297 Human LAR ELISA Kit (AC3708) Quantitative inquiry ASET-2169 Human Thrombospondin 1 ELISA Kit (AC3580) Quantitative inquiry ASET-1713 Human CABP ELISA Kit (AC3124) Quantitative inquiry ASET-1328 Human ZFYVE27 ELISA Kit (AC2739) Quantitative inquiry ASET-1386 Mouse NMDAR1 ELISA Kit (AC2797) Quantitative inquiry ASET-1066 Human UNC5B ELISA Kit (AC2477) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket